Presystemic elimination of trichloroethylene in rats following environmentally relevant oral exposures

Drug Metabolism and Disposition

Volumn 37, Issue 10, 2009, Pages 1994-1998

  Liu, Y ^a   Bartlett, M G ^a   White, C A ^a   Muralidhara, S ^a   Bruckner, James V ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTERY CATHETERIZATION; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG EXPOSURE; DRUG MEGADOSE; HYPOTHESIS; KINETICS; LIVER; LOW DRUG DOSE; LUNG; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID PHASE MICROEXTRACTION; TIME;

ANIMALS; BIOLOGICAL AVAILABILITY; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SOLID PHASE MICROEXTRACTION; TISSUE DISTRIBUTION; TRICHLOROETHYLENE; UNITED STATES;

MUS; RATTUS;

EID: 70349268330     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.109.028100     Document Type: Article

References (37)

1. Andersen ME (1981) A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: analysis at steady state. Toxicol Appl Pharmacol 60:509-526.
2. Andersen ME, Eklund CR, Mille JJ, Barton HA, and Birnbaum LS (1997) A multicompartment geometric model of the liver in relation to regional induction of cytochrome P450s. Toxicol Appl Pharmacol 144:135-144.
3. Blount BC, Kovelski RJ, McElprang DO, Ashley DL, Marrow JC, Chambers DM, and Cardinali FL (2006) Quantitation of volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrophotometry. J Chromatogr B 832:292-301. (Pubitemid 43339961)
4. Bogen KT (1988) Pharmacokinetics of regulatory risk analysis: the case of trichloroethylene. Regul Toxicol Pharmacol 8:447-466. (Pubitemid 19014886)
5. Bull RJ (2000) Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ Health Perspect 108 (Suppl 2):241-259.
6. Caldwell JC and Keshava N (2006) Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis. Environ Health Perspect 114:1457-1463.
7. Churchill JE, Ashley DL, and Kaye WE (2001) Recent chemical exposures and blood volatile organic compound levels in a large population-based sample. Arch Environ Health 56:157-166. (Pubitemid 32382469)
8. Clewell HJ and Andersen ME (2004) Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol 34:385-445.
9. Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, et al. (2004) Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78:181-186. (Pubitemid 38559665)
10. Fisher JW, Mahle D, and Abbas R (1998) A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol Appl Pharmacol 152:339-359. (Pubitemid 28492276)
11. Forkert P-G, Baldwin RM, Millen B, Lash LH, Putt DA, Shultz MA, and Collins KS (2005) Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1. Drug Metab Dispos 33:1429-1437. (Pubitemid 41323989)
12. Forkert P-G, Lash LH, Nadeau V, Tardif R, and Simmonds A (2002) Metabolism and toxicity of trichloroethylene in epididymis and testis. Toxicol Appl Pharmacol 182:244-254.
13. Forkert P-G, Millen B, Lash LH, Putt DA, and Ghanayem BI (2006) Pulmonary bronchiolar cytotoxicity and formation of dichloroacetyl lysine protein adducts in mice treated with trichloroethylene. J Pharmacol Exp Ther 316:520-529. (Pubitemid 43130977)
14. Frederick CB, Potter DW, Chang-Mateu MI, and Andersen ME (1992) A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol Appl Pharmacol 114:246-260.
15. Gargas ML, Burgess RJ, Voisard DE, Cason GH, and Andersen ME (1989) Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 98:87-99. (Pubitemid 19094137)
16. Gebhardt R (1989) Metabolic zonation in the liver: regulation and implications for liver function. Pharmacol Ther 53:275-354.
17. Hall SD, Thummel KE, Watkins PB, Lown KS, Benet LZ, Paine MF, Mayo RR, Turgeon DK, Bailey DG, Fontana RJ, et al. (1999) Molecular and physical mechanisms of first-pass extraction. Drug Metab Dispos 27:161-166.
18. Kaminsky LS and Zhang Q-Y (2003) The small intestine as a xenobiotics-metabolizing organ. Drug Metab Dispos 31:1520-1525.
19. Kedderis GL (1997) Extrapolation of in vitro enzyme induction data to humans in vivo. Chem Biol Interact 107:109-121.
20. Keys DA, Bruckner JV, Muralidhara S, and Fisher JW (2003) Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene. Toxicol Sci 76:35-50. (Pubitemid 37361883)
21. Lash LH, Fisher JW, Lipscomb JC, and Parker JC (2000a) Metabolism of trichloroethylene. Environ Health Perspect 108 (Suppl 2):177-200.
22. Lash LH, Parker JC, and Scott CSD (2000b) Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect 108 (Suppl 2):225-240.
23. Lash LH, Putt DA, and Parker JC (2006) Metabolism and tissue distribution of orally administered trichloroethylene in male and female rats. Identification of glutathione- and cytochrome P-450-derived metabolites in liver, kidney, blood and urine. J Toxicol Environ Health A 69:1285-1309.
24. Lee KM, Bruckner JV, Muralidhara S, and Gallo JM (1996) Characterization of presystemic elimination of trichloroethylene and its nonlinear kinetics in rats. Toxicol Appl Pharmacol 139:262-271. (Pubitemid 26281602)
25. Lipscomb JC, Garrett CM, and Snawder JE (1997) Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans. Toxicol Appl Pharmacol 142:311-318.
26. Lipscomb JC, Teuschler LK, Swartout J, Popken D, Cox T, and Kedderis GL (2003) The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans. Risk Anal 23:1221-1238. (Pubitemid 38045102)
27. Liu Y, Muralidhara S, Bruckner JV, and Bartlett MG (2008a) Determination of trichloroethylene in biological samples by headspace solid-phase microextraction gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 863:26-35.
28. Liu Y, Muralidhara S, Bruckner JV, and Bartlett MG (2008b) Trace level determination of trichloroethylene in biological samples by headspace solid phase microextraction gas chromatography/negative chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 22:797-806.
29. Liu L and Pang KS (2006) An integrated approach to model hepatic drug clearance. Eur J Pharm Sci 29:215-230. (Pubitemid 44602411)
30. Lock EA and Reed CJ (2006) Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol Sci 91:313-331. (Pubitemid 43827285)
31. Moran MJ, Zogorski JS, and Squillace PJ (2007) Chlorinated solvents in groundwater of the United States. Environ Sci Technol 41:74-81.
32. National Research Council (1986) Dose route extrapolation: Using inhalation toxicity data to set drinking water limits. In Drinking Water and Health, vol 6, ch 6, National Academy Press, Washington, DC.
33. National Research Council (2006) Assessing the Human Health Risks of Trichloroethylene. Key Scientific Issues. National Academies Press, Washington, D.C.
34. Oinonen T and Lindros KO (1998) Zonation of hepatic cytochrome P-450 expression and regulation. Biochem J 329:17-35. (Pubitemid 28022286)
35. Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, and Zeldin DC (2006) The human intestinal cytochrome P450 "pie". Drug Metab Dispos 34:880-886.
36. Ramdhan DH, Kamijima M, Yamada N, Ito Y, Yanagiba Y, Nakamura D, Okamura A, Ichihara G, Aoyama T, et al. (2008) Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1. Toxicol Appl Pharmacol 231:300-307.
37. Weisel CP and Jo WK (1996) Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water. Environ Health Perspect 104:48-51.